NYSE:MDT - New York Stock Exchange, Inc. - IE00BTN1Y115 - Common Stock - Currency: USD
MEDTRONIC PLC
NYSE:MDT (1/28/2025, 8:04:00 PM)
After market: 91.79 -0.19 (-0.21%)91.98
-0.48 (-0.52%)
The current stock price of MDT is 91.98 USD. In the past month the price increased by 12.72%. In the past year, price increased by 4.96%.
Top S&P500 movers in Tuesday's session
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.
This medtech giant is leveraging the power of artificial intelligence for a strong growth outlook.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.28 | 220.95B | ||
ISRG | INTUITIVE SURGICAL INC | 78.33 | 204.50B | ||
BSX | BOSTON SCIENTIFIC CORP | 43.36 | 150.80B | ||
SYK | STRYKER CORP | 33.95 | 150.64B | ||
BDX | BECTON DICKINSON AND CO | 18.93 | 72.24B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.18 | 42.80B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.8 | 40.10B | ||
RMD | RESMED INC | 30.15 | 36.69B | ||
DXCM | DEXCOM INC | 51.97 | 34.51B | ||
IDXX | IDEXX LABORATORIES INC | 38.16 | 34.21B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 20.15 | 25.57B | ||
ZBH | ZIMMER BIOMET HOLDINGS INC | 14.18 | 22.27B |
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The company is headquartered in Dublin, Dublin and currently employs 95,000 full-time employees. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
MEDTRONIC PLC
Building Two Parkmore Business Park West
DUBLIN DUBLIN D02 IE
CEO: Geoffrey S. Martha
Employees: 95000
Company Website: https://www.medtronic.com/
Investor Relations: https://investorrelations.medtronic.com
Phone: 1135314381700
The current stock price of MDT is 91.98 USD.
The exchange symbol of MEDTRONIC PLC is MDT and it is listed on the New York Stock Exchange, Inc. exchange.
MDT stock is listed on the New York Stock Exchange, Inc. exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for MDT, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of MDT.
MDT has a dividend yield of 3.14%. The yearly dividend amount is currently 2.77.
MDT will report earnings on 2025-02-18, after the market close.
The PE ratio for MDT is 17.52. This is based on the reported non-GAAP earnings per share of 5.25 and the current share price of 91.98 USD.
The outstanding short interest for MDT is 0.77% of its float.
ChartMill assigns a technical rating of 8 / 10 to MDT. When comparing the yearly performance of all stocks, MDT turns out to be only a medium performer in the overall market: it outperformed 51.75% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to MDT. While MDT has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months MDT reported a non-GAAP Earnings per Share(EPS) of 5.25. The EPS increased by -1.32% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 13% | ||
ROA | 4.76% | ||
ROE | 8.84% | ||
Debt/Equity | 0.51 |
ChartMill assigns a Buy % Consensus number of 71% to MDT. The Buy consensus is the average rating of analysts ratings from 37 analysts.
For the next year, analysts expect an EPS growth of 5.7% and a revenue growth 4.06% for MDT